Fertility and Sterility: A Current OverviewJ. Bringer, B. Hedon CRC Press, 15 Σεπ 1995 - 498 σελίδες This is the most complete and up-to-date medical reference work available on the newest clinical developments and scientific findings dealing with contraception, infertility, the endocrinology of reproduction, andrology, reproductive surgery, IVF technology, ethics, and research on human fertility and sterility. It contains 65 chapters by prominent international authorities. As the volume editors state in their Foreword, Whether you are a gynecologist, endocrinologist, biologist, andrologist, or basic scientist, or whatever your own interest-reproductive surgery, assisted medical procreation techniques, new drugs, contraception, reproductive endocrinology, or perhaps all of these-you will find that this book contains the appropriate answers. |
Περιεχόμενα
The evolution of contraceptive methods and practices to the year 2000 | 15 |
Advances in oral hormonal contraception 776 | 21 |
Advances in intrauterine device technology | 31 |
Combined injectable preparations and introduction as a new method 177 | 47 |
New concepts on the etiology of endometriosis | 57 |
Medical treatment of endometriosis | 63 |
Diagnosis of polycystic ovarian syndrome | 71 |
medical therapy 85 65 | 85 |
Cytokines and spermatogenesis | 249 |
Molecular genetics of the androgen receptor | 263 |
The clinical and molecular spectrum of disorders of the androgen receptor | 279 |
Assessment of sperm concentration | 297 |
Fertilization capacity | 311 |
Acquired immunodeficiency syndrome and donor insemination | 329 |
Endoscopic surgery of peritoneal ovarian and rectovaginal septum endometriosis | 345 |
characteristics of patients | 361 |
Doppler ultrasound in fertility 93 38 | 93 |
Sporadic and recurrent abortion | 105 |
Immunological and hematological abnormalities and recurrent | 119 |
evaluation of outcome | 135 |
Influences of nutrition on the menstrual cycle and fertility in women | 163 |
Female age and fecundity | 181 |
Antiprogestins and the implantation process | 199 |
Outcome and longterm followup after ovarian stimulation | 215 |
The potential relevance of inhibin and activin to placental physiology | 231 |
Womens age and assisted medical procreation | 379 |
Microinsemination | 395 |
Followup of children born after intracytoplasmic sperm injection | 409 |
Fluorescent in situ hybridization in human blastomeres | 425 |
Fate of disposable embryos | 439 |
Ethical aspects of surrogacy | 455 |
Analysis of clinical research | 461 |
Συχνά εμφανιζόμενοι όροι και φράσεις
abnormalities acrosin acrosome activin activity androgen receptor androgen receptor gene aneuploidy antibodies apoptosis assessment binding Biol chromosome Clin clinical contraceptive cytokines decrease detected diagnosis disease dose effect embryo transfer endo Endocrinol Endocrinology endometrial endometriosis endometrium estradiol estrogen female fetal fluid follicles follicular FSH levels function Genet gestation GnRH gonadotropin granulosa cells growth factor Gynecol Health hormone human ICSI IGF-I implantation increase induced infertility inhibin insulin intracytoplasmic sperm injection laparoscopy luteal male malformations maternal menstrual cycle ment Metab metriosis mifepristone mRNA mutations normal Obstet OHSS oocytes oral contraceptives ovarian ovulation patients PCOS phase placental plasma polycystic ovary syndrome population pregnancy pregnancy rates progesterone protein recurrent reported Reprod reproductive risk role semen serum spermatozoa spontaneous abortion Steril steroid stimulation testicular therapy tion tissue tive treatment tubal tumor uterine vaginal vaginismus vitro fertilization women